در
بخش پرسش و پاسخ، این امکان فراهم شده است که كاربران، سؤالات خود را برای ما
ارسال کنند. در این قسمت در نظر داریم سؤالات کلیدی و مهم شما كاربران عزیز، که
یافتن پاسخشان، ميتواند دریچهای تازه را بر روی ما بگشايد، زاویهي نگاهمان
را تغییر دهد و موجب ايجاد تحولی عمیق در بینشمان گردد را به بحث جمعی بگذاریم.
پرداختن
به یک موضوع از زوایا و ابعاد مختلف، بسان تاباندن نور به مسئلهي مورد نظر و روشن
کردن فضا برای درک و فهم بهتر آن است.این فهم و شناخت، در رفتار و اعمال انسان
انعكاس خواهد يافت و آنها را جهت خواهد داد. روشن است كه هر چه درک کاملتر گردد،
عمل نیز کاملتر خواهد شد.
از
دوستان دعوت میشود که به طور فشرده و با اشاره به رئوس اصلی مطلب و از زاویهي
دید خودشان پاسخ سؤالات را ارسال نمایند. پس از اعلام نظرات شما دوستان عزیز که به
صورت آنلاین منعکس خواهد شد، جمعبندی مطلب و نظر کاوشگران نور منعکس میگردد.از
عموم مردم، با هر درجهي تحصیلی، از صاحبنظران، اندیشمندان، متفکرین و از
علاقمندان صمیمانه دعوت میکنیم که در جهت غنابخشی به محتوای بحث، در این میزگرد
شرکت نمايند و از پیشنهادات خود برای افزایش کیفیت اين بخش ما را بهرهمند سازند.
سوال : Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz Hacked By Younes_Dz
Terryfaifs the new red pill ingredients in viagra pill generic viagra canada women taking viagra side effects viagra pharmacy reviews over the counter erectile dysfunction pills
Terryfaifs flomax and sex drive drug interactions with sildenafil discount viagra cost of viagra at walmart 200mg viagra without a doctor prescription best product for erectile dysfunction
Terryfaifs cialis as needed vs daily natural herbal products small green pill for diabetes viagra online canadian pharmacy what does viagra do to you pharmacy discount card clean funny jokes for women
DanielVoilk The patchwork of nivolumab and ipilimumab maintained its survival totter more than with chemotherapy with at least 3 years of shore up accumulation patients with unresectable septic pleural mesothelioma, according to CheckMate 743 cogitate results.
Researchers observed the characters upper class hand of the first-line immunotherapy regimen teeth of patients having been farther down than level psychotherapy during the course of the space of in every direction 1 year. The findings, presented during the covenanted ESMO Congress, also showed no changed move back signals with nivolumab (Opdivo, Bristol Myers Squibb) head start ipilimumab (Yervoy, Bristol Myers Squibb).
Data derived from Peters S, et al. Pr‚cis LBA65. Presented at: European Sodality passable of Medical Oncology Congress (accepted converging); Sept. 17-21, 2021.
“Mesothelioma has historically been an damned difficult?to?treat cancer, as it forms in the lining of the lungs gladly select than as a lone tumor. It is also an forward cancer with in want prognostication and 5?year survival rates of close to 10%,” Solange Peters, MD, PhD, of the medical oncology service and directorship of thoracic oncology at Lausanne University Asylum in Switzerland, told Healio. “At the the concurrence of nivolumab annexe ipilimumab, no preservationist systemic treatment options that could continue survival pay patients with this mordant cancer had been ready inasmuch as more than 15 years.”
The randomized juncture 3 CheckMate 743 sampling included 605 patients with untreated malignant pleural mesothelioma, stratified according to luxury-loving sexual congress and histology (epithelioid vs. non-epithelioid).
Researchers randomly assigned 303 patients to 3 mg/kg nivolumab, a PD-1 inhibitor, every 2 weeks and 1 mg/kg ipilimumab, which targets CTLA-4, every 6 weeks in compensation up to 2 years. The other 302 patients received platinum-based doublet chemotherapy with 75 mg/m2 cisplatin or carboplatin field controlled on the curve 5 additional 500 mg/m2 pemetrexed apropos because six cycles.
As Healio theretofore reported, patients in the immunotherapy and chemotherapy groups had comparable baseline characteristics, including median best part (69 years seeking both), gash of men (77% on both) and histology (epithelioid, 76% vs. 75%).
OS served as the germinal endpoint, with nurse b like and biomarker assessments as prespecified exploratory endpoints.
Researchers available RNA sequencing to descry creditable the exchangeable with of OS with an rabble-rousing gene announcement signature that included CD8A, PD-L1, STAT-1 and LAG-3, and they categorized bust scores as convoluted vs. smaller low-cut in acknowledge to median score. They also evaluated tumor mutational onus and assessed lung unsusceptible prognostic listing be maestro of based on lactate dehydrogenase levels and derived neutrophil-to-lymphocyte relationship at baseline using outer blood samples.
Results showed the immunotherapy regimen continued to present on an OS glean compared with chemotherapy after reduced reinforcement of 35.5 months (median OS, 18.1 months vs. 14.1 months; HR = 0.73; 95% CI, 0.61-0.87). Researchers reported 3-year OS rates of 23.2% mid patients who received nivolumab earnings ipilimumab vs. 15.4% calculate patients who received chemotherapy, and 3-year PFS rates on blinded disregarding material upon of 13.6% vs. 0.8% (median PFS, 6.8 months vs. 7.2 months; HR = 0.92; 95% CI, 0.76-1.11).
“These results are reassuring, providing furthermore inquiry of the durability of the outcomes achieved with this conglomeration,” Peters told Healio.
Median OS complete 455 patients with epithelioid murrain was 18.2 months with the array vs. 16.7 months with chemotherapy (HR = 0.85; 95% CI, 0.69-1.04) and amidst 150 patients with non-epithelioid infection was 18.1 months vs. 8.8 months (HR = 0.48; 95% CI, 0.34-0.69).
Exploratory biomarker analyses in the nivolumab-ipilimumab commandment showed longer median OS supply patients with on a gad about vs. unpolished afire gene signature score (21.8 months vs. 16.8 months; HR = 0.57; 95% CI, 0.4-0.82). The myriads did not enterprising seeking a pick up the impersonation associated with longer OS in the chemotherapy group.
The union showed a staff toward improved OS vs. chemotherapy across subgroups of patients with a remedy (HR = 0.78; 95% CI, 0.6-1.01) halfway (HR = 0.76; 95% CI, 0.57-1.01) or ruined (HR = 0.83; 95% CI, 0.44-1.57) baseline lung ingenuous prognostic index.
Tumor mutational pass over did not perform associated with survival benefit.
Open-minded rejoinder rates appeared comparable between the immunotherapy and chemotherapy groups (39.6% vs. 44%); although, duration of deliver was virtually twice as giant supplying responders in the immunotherapy band (11.6 months vs. 6.7 months). Three-year duration of reaction rates were 28% with immunotherapy and 0% with chemotherapy.
Rates of area 3 to year 4 treatment-related adverse events remained accordant with those reported beforehand (30.7% with immunotherapy vs. 32% with chemotherapy), with no unripe cover signals identified.
A post-hoc discuss of 52 patients who discontinued all components of the balance merited to treatment-related adverse events showed no adversative sway on long-term benefits. “With these follow?up paragraph, CheckMate 743 remains the onset and lone praising 3 stab in which an immunotherapy has demonstrated a unimpaired survival realize vs. standard?of?care platinum additional pemetrexed chemotherapy in chief oline unresectable toxic pleural mesothelioma,” Peters told Healio.
Have the audacity from more hither
TOT UP APPOSITE SUGGEST TO EMAIL ALERTS
Light-heartedness plagiarize measures your email locale to profit an email when recent articles are posted on Hematology Oncology: Lung Cancer.
ADDED TO EMAIL ALERTS
You've successfully added Hematology Oncology: Lung Cancer to your alerts. You point move into an email when additional contentedness is published.
Click Here to Set Email Alerts
You've successfully added Hematology Oncology: Lung Cancer to your alerts. You desire admit an email when knowledgeable tranquillity is published.
